Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
The EMBO Journal|August 13, 2003
Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau proteinXi Na, Hai Ou Duan, Edward M Messing, et al.Science (New York, N.Y.)|June 11, 1993
A nonpeptidyl growth hormone secretagogueR G Smith, K Cheng, W R Schoen, et al.Bioorganic & Medicinal Chemistry Letters|November 27, 1999
Acyclic structural variants of growth hormone secretagogue L-692,429P Lin, J M Pisano, W R Schoen, et al.Journal of Medicinal Chemistry|September 1, 1988
Phosphinic acid inhibitors of D-alanyl-D-alanine ligaseW H Parsons, A A Patchett, H G Bull, et al.Journal of Medicinal Chemistry|April 1, 1994
A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429)W R Schoen, J M Pisano, K Prendergast, et al.Global Change Biology|October 8, 2024
Body size and early marine conditions drive changes in Chinook salmon productivity across northern latitude ecosystemsMegan L Feddern, Rebecca Shaftel, Erik R Schoen, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2002
Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesisRoger A Smith, Donald L Hertzog, Martin H Osterhout, et al.Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonistsGaetan H Ladouceur, James H Cook, Donald L Hertzog, et al.Journal of Medicinal Chemistry|May 30, 1998
A potent, orally bioavailable benzazepinone growth hormone secretagogueR J DeVita, R Bochis, A J Frontier, et al.Kidney International|June 18, 2015
Disruption of tubular Flcn expression as a mouse model for renal tumor inductionJindong Chen, Dachuan Huang, Isabelle Rubera, et al.Pageof 9